Arkansas Code Title 20, Subtitle 2, Chapter 15, Subchapter 21 - Right to Try Act

  • § 20-15-2101 - Title.
    This subchapter shall be known and may be cited as the "Right to Try Act".
  • § 20-15-2102 - Findings.
    It is found and determined by the General Assembly of the State of Arkansas that: (1) The process of approval for investigational drugs, biological...
  • § 20-15-2103 - Definitions.
    As used in this subchapter: (1) "Eligible patient" means a person who meets the requirements of eligibility in ยง 20-15-2104; (2) "Investigational drug, biological...
  • § 20-15-2104 - Eligibility.
    In order for a patient to access an investigational drug, biological product, or device under this subchapter, a physician must document in the patient's...
  • § 20-15-2105 - Availability.
    A manufacturer of an investigational drug, biological product, or device may, but is not required to, make its investigational drug, biological product, or device...
  • § 20-15-2106 - Costs.
    (a) A manufacturer of an investigational drug, biological product, or device may: (1) Provide an investigational drug, biological product, or device to an eligible...
  • § 20-15-2107 - Insurance Coverage.
    An insurance company: (1) May, but is not required to, provide coverage for an investigational drug, biological product, or device; and (2) Shall not...
  • § 20-15-2108 - Prohibited Sanctions.
    The recommendation, prescription, treatment, or participation in the treatment of a terminal illness with an investigational drug, biological product, or device shall not permit:...
  • § 20-15-2109 - Remedy.
    The counseling, advice, or recommendation by a medical professional who is licensed under state law is not a violation of this subchapter.
  • § 20-15-2110 - Immunity.
    (a) Except in the case of gross negligence or willful misconduct, a person or entity that manufacturers, imports, distributes, prescribes, dispenses, administers, or is...
  • § 20-15-2111 - Medicaid Coverage.
    This subchapter does not require the Department of Human Services or the Arkansas Medicaid Program to provide additional coverage for an investigational drug, biological...

Last modified: November 15, 2016